Amarin Corporation PLC to Present at the Canaccord Genuity 33rd Annual Growth Conference

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

BEDMINSTER, N.J. and DUBLIN, Ireland, Aug. 13, 2013 (GLOBE NEWSWIRE) -- Amarin Corporation plc (Nasdaq:AMRN), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, announced that John F. Thero, Amarin’s President, is scheduled to present a general company update at the Canaccord Genuity 33rd Annual Growth Conference on Thursday, August 15, 2013, at 4:00 p.m. ET.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC